NCT03336606View on ClinicalTrials.gov

Study of MEDI0562 Prior to Surgical Resection in Head and Neck Squamous Cell Carcinoma (HNSCC) or Melanoma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

June 1, 2026

Study Completion Date

December 1, 2026

Conditions
Head and Neck CancerHead and Neck Squamous Cell CarcinomaMelanomaCell Cancer, SquamousCarcinoma, Squamous Cell
Interventions
DRUG

MEDI0562

Surgical resection of tumor

Trial Locations (1)

97213

Providence Portland Medical Center, Portland

Sponsors

Collaborators (1)

MedImmune LLC
All Listed Sponsors
collaborator

Providence Cancer Center, Earle A. Chiles Research Institute

OTHER

collaborator

MedImmune LLC

INDUSTRY

lead

Providence Health & Services

OTHER